Shanghai, China

Chaohui Dai

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Shanghai Hyamab Biotech Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chaohui Dai. Retrieved from https://idiyas.com/inventor/chaohui-dai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chaohui Dai: Innovator in Antibody Development

Introduction

Chaohui Dai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work is characterized by a commitment to advancing medical science and improving therapeutic options.

Latest Patents

Chaohui Dai holds a patent for the "NKG2A Antibody, Preparation Method Therefor and Application Thereof." This innovative patent reflects his expertise in antibody development and its potential applications in treating various diseases.

Career Highlights

Dai is currently associated with Shanghai Hyamab Biotech Co., Ltd., where he continues to push the boundaries of biotechnology. His work at the company has positioned him as a key player in the field, contributing to the advancement of therapeutic antibodies.

Collaborations

Chaohui Dai collaborates with talented individuals such as Qing Duan and Lile Liu. These partnerships enhance the research and development efforts at Shanghai Hyamab Biotech Co., Ltd., fostering innovation and creativity.

Conclusion

Chaohui Dai's contributions to antibody development exemplify the spirit of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…